IL145733A0 - A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same - Google Patents
A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the sameInfo
- Publication number
- IL145733A0 IL145733A0 IL14573300A IL14573300A IL145733A0 IL 145733 A0 IL145733 A0 IL 145733A0 IL 14573300 A IL14573300 A IL 14573300A IL 14573300 A IL14573300 A IL 14573300A IL 145733 A0 IL145733 A0 IL 145733A0
- Authority
- IL
- Israel
- Prior art keywords
- polpyeptide
- pharmaceutical compositions
- same
- immunogenic portion
- compositions containing
- Prior art date
Links
- 210000000481 breast Anatomy 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28895099A | 1999-04-09 | 1999-04-09 | |
US09/346,327 US6410507B1 (en) | 1997-12-24 | 1999-07-02 | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
PCT/US2000/009688 WO2000061756A2 (en) | 1999-04-09 | 2000-04-10 | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145733A0 true IL145733A0 (en) | 2002-07-25 |
Family
ID=26965353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14573300A IL145733A0 (en) | 1999-04-09 | 2000-04-10 | A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same |
Country Status (16)
Country | Link |
---|---|
US (1) | US6410507B1 (no) |
EP (1) | EP1169446A2 (no) |
JP (1) | JP2002541805A (no) |
KR (1) | KR20020007362A (no) |
CN (1) | CN1355844A (no) |
AU (1) | AU4231300A (no) |
BR (1) | BR0009608A (no) |
CA (1) | CA2365912A1 (no) |
CZ (1) | CZ20013576A3 (no) |
HK (1) | HK1047135A1 (no) |
HU (1) | HUP0200991A2 (no) |
IL (1) | IL145733A0 (no) |
NO (1) | NO20014804L (no) |
PL (1) | PL350890A1 (no) |
TR (1) | TR200103786T2 (no) |
WO (1) | WO2000061756A2 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030185830A1 (en) * | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US20040033230A1 (en) * | 1997-12-24 | 2004-02-19 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US20030003507A1 (en) | 1999-06-02 | 2003-01-02 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
WO2001035811A2 (en) * | 1999-11-16 | 2001-05-25 | Eos Biotechnology, Inc. | Methods of diagnosing and determining prognosis of breast cancer |
US20040142361A1 (en) * | 1999-11-30 | 2004-07-22 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US20020146727A1 (en) * | 1999-11-30 | 2002-10-10 | Dillon Davin C. | Compositions and methods for the therapy and diagnosis of breast cancer |
EP1248800A2 (en) | 1999-11-30 | 2002-10-16 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
EP1259611A2 (en) * | 2000-03-03 | 2002-11-27 | Incyte Genomics, Inc. | G-protein coupled receptors |
EP2014298A3 (en) * | 2000-08-24 | 2009-10-07 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
EP1988097A1 (en) * | 2001-05-09 | 2008-11-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US20040162236A1 (en) * | 2002-04-01 | 2004-08-19 | John Alsobrook | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
WO2003090600A2 (en) * | 2002-04-23 | 2003-11-06 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
US9517240B2 (en) | 2006-09-26 | 2016-12-13 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
US20100160275A1 (en) * | 2006-09-26 | 2010-06-24 | Lee Eva Y H P | Methods and compositions for cancer prevention and treatment |
CN104619840A (zh) * | 2012-07-05 | 2015-05-13 | 日本国立癌症研究中心 | Fgfr2融合基因 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015571A (en) * | 1983-08-17 | 1991-05-14 | Scripps Clinic And Research Foundation | Polypeptide-induced monoclonal receptors to protein ligands |
US5662907A (en) | 1992-08-07 | 1997-09-02 | Cytel Corporation | Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes |
EP0692973A1 (en) | 1993-03-15 | 1996-01-24 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Peptide coated dendritic cells as immunogens |
US5763164A (en) | 1993-04-16 | 1998-06-09 | Northwestern University | Immunogenic cancer proteins and peptides and methods of use |
AU695540B2 (en) | 1993-10-27 | 1998-08-13 | Trustees Of Columbia University In The City Of New York, The | Method for generating a subtracted cDNA library and uses of the generated library |
AU8116494A (en) | 1993-11-12 | 1995-06-13 | Kenichi Matsubara | Gene signature |
JPH11509093A (ja) | 1995-06-30 | 1999-08-17 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | 乳房特異的遺伝子およびタンパク質 |
KR19990077146A (ko) | 1996-01-11 | 1999-10-25 | 길리스 스티브 | 유방암의 치료 및 진단용 조성물 및 방법 |
EP0923605A4 (en) | 1996-03-20 | 2003-01-02 | Sloan Kettering Inst Cancer | CONJUGATE VACCINES CONTAINING MUCIN PEPTIDE |
CA2269634C (en) | 1996-10-31 | 2010-08-17 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
JP2002507387A (ja) | 1997-12-24 | 2002-03-12 | コリクサ コーポレイション | 乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法 |
-
1999
- 1999-07-02 US US09/346,327 patent/US6410507B1/en not_active Expired - Fee Related
-
2000
- 2000-04-10 IL IL14573300A patent/IL145733A0/xx unknown
- 2000-04-10 PL PL00350890A patent/PL350890A1/xx unknown
- 2000-04-10 CZ CZ20013576A patent/CZ20013576A3/cs unknown
- 2000-04-10 CN CN00807046A patent/CN1355844A/zh active Pending
- 2000-04-10 EP EP00922073A patent/EP1169446A2/en not_active Withdrawn
- 2000-04-10 WO PCT/US2000/009688 patent/WO2000061756A2/en not_active Application Discontinuation
- 2000-04-10 BR BR0009608-3A patent/BR0009608A/pt not_active Application Discontinuation
- 2000-04-10 AU AU42313/00A patent/AU4231300A/en not_active Abandoned
- 2000-04-10 TR TR2001/03786T patent/TR200103786T2/xx unknown
- 2000-04-10 HU HU0200991A patent/HUP0200991A2/hu unknown
- 2000-04-10 CA CA002365912A patent/CA2365912A1/en not_active Abandoned
- 2000-04-10 JP JP2000611679A patent/JP2002541805A/ja not_active Withdrawn
- 2000-04-10 KR KR1020017012893A patent/KR20020007362A/ko not_active Application Discontinuation
-
2001
- 2001-10-03 NO NO20014804A patent/NO20014804L/no not_active Application Discontinuation
-
2002
- 2002-12-03 HK HK02108767.2A patent/HK1047135A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BR0009608A (pt) | 2002-01-08 |
US6410507B1 (en) | 2002-06-25 |
TR200103786T2 (tr) | 2002-06-21 |
KR20020007362A (ko) | 2002-01-26 |
CZ20013576A3 (cs) | 2002-10-16 |
NO20014804L (no) | 2001-11-15 |
EP1169446A2 (en) | 2002-01-09 |
WO2000061756A3 (en) | 2001-02-08 |
PL350890A1 (en) | 2003-02-10 |
NO20014804D0 (no) | 2001-10-03 |
CN1355844A (zh) | 2002-06-26 |
CA2365912A1 (en) | 2000-10-19 |
WO2000061756A2 (en) | 2000-10-19 |
HK1047135A1 (zh) | 2003-02-07 |
AU4231300A (en) | 2000-11-14 |
HUP0200991A2 (en) | 2002-07-29 |
JP2002541805A (ja) | 2002-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145620A0 (en) | A polypeptide containing an immunogenic portion of a breast tumor protein and pharmaceutical compositions containing the same | |
IL142216A0 (en) | A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same | |
IL150224A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
IL150223A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
IL149754A0 (en) | Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same | |
EP0950665A4 (en) | PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM | |
HK1040995A1 (zh) | 二氧喹啉化合物及其醫藥用途 | |
CZ20011518A3 (cs) | Farmaceutický prostředek | |
HUP0202338A2 (en) | Pharmaceutical composition containing fenofibrate and preparation method | |
HUP0200548A2 (hu) | Gyógyszerészeti készítmények és alkalmazásuk | |
HK1044476A1 (en) | Medicinal compositions | |
HUP0202862A3 (en) | Pharmaceutical composition containing novel combination of loteprednol and antihistamines | |
IL145733A0 (en) | A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same | |
EP1166786A4 (en) | MEDICAL COMPOSITIONS | |
IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
HU9800147D0 (en) | Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them | |
AP2001002371A0 (en) | Streptogramin derivatives preparation and compositions containing them | |
HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
IL125908A0 (en) | Peptides and pharmaceutical compositions comprising same | |
EP1173216A4 (en) | PHARMACEUTICAL FORMULATIONS | |
IL131266A0 (en) | Peptides and pharmaceutical compositions comprising same | |
IL150904A0 (en) | Cyclic hexapeptide derivatives and pharmaceutical compositions containing the same | |
EP1142589A4 (en) | MEDICAL COMPOSITIONS | |
HUP0201443A2 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them | |
HUP0003159A3 (en) | The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions |